Rare Collagenous Heterozygote Variants in Children With IgA Nephropathy - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Kidney International Reports Année : 2021

Rare Collagenous Heterozygote Variants in Children With IgA Nephropathy

Résumé

Introduction: Childhood IgA nephropathy (cIgAN) is a primary glomerulonephritis clinically characterized by microscopic hematuria and proteinuria, the presence of which may potentially overlap with Alport syndrome. Interestingly, earlier studies suggested that familial IgAN could be linked to the chromosome 2q36 region, also the coding region for collagen type 4 alpha 3/4 (COL4A3/A4). Methods: To investigate a possible relationship or phenocopy between Alport syndrome and cIgAN, COL4A3, COL4A4, and COL4A5 exons were sequenced in 36 cIgAN patients. Clinical data and treatment were collected retrospectively. COL4A3/A4/A5 variants were classified according to American College of Medical Genetics and the Association for Molecular Pathology (ACMG/AMP) guidelines. Results: Four of 36 cIgAN patients were affected by ACMG class 4/5 COL4A3 heterozygous variants (COL4A3-cIgAN). We found no COL4A4 or COL4A5 variant. Despite having rare and deleterious COL4A3 variants, 3 of 4 COL4A3-cIgAN children developed clinical and biologic features of active IgAN rather than Alport syndrome. Response to intensive immunosuppressive treatment was favorable, leading to a reduction of endocapillary and extracapillary proliferation lesions. High levels of immune immunoglobulin G and A (IgG/IgA) complexes, reduction of proteinuria, and gradual stabilization of estimated glomerular filtration rate (eGFR) argued against Alport syndrome. Nevertheless, COL4A3-cIgAN patients seemed predisposed to a more serious IgAN presentation compared with the non‒COL4A3-cIgAN group, with more glomerulosclerosis and a lower eGFR over time. One of the 4 patients underwent kidney transplant with subsequent IgAN recurrence. Conclusions: Predisposition factors for developing serious cIgAN flare-up should be considered for cIgAN with COL4A3 pathologic heterozygous variants. COL4A3 variants, usually responsible for Alport syndrome in adults, should not automatically exclude an immunosuppressive regimen in cIgAN. Moreover, evidence of an ACMG class 4/5 COL4A3 variant in early-stage cIgAN could be a helpful tool for stratifying severity of cIgAN beyond the Oxford classification.
Fichier principal
Vignette du fichier
1-s2.0-S2468024921000930-main.pdf (415.41 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03232426 , version 1 (21-05-2021)

Identifiants

Citer

Alexandra Cambier, Thomas Robert, Julien Hogan, Marion Rabant, Michel Peuchmaur, et al.. Rare Collagenous Heterozygote Variants in Children With IgA Nephropathy. Kidney International Reports, 2021, 6 (5), pp.1326 - 1335. ⟨10.1016/j.ekir.2021.02.022⟩. ⟨hal-03232426⟩
95 Consultations
49 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More